{
    "info": {
        "nct_id": "NCT06130280",
        "official_title": "Ablative Dose Single Fraction MRguided Colorectal Liver Metastasis SBRT",
        "inclusion_criteria": "* Age ≥18\n* Histologically confirmed colorectal carcinoma and evidence of liver metastasis on imaging\n* ECOG 0-2\n* <=3 liver lesions measurable on contrast enhanced diagnostic MRI with combined size (sum of longest diameters) < 7 cm, and individual size < 5cm. (Subsequent simulation scans will not be used for eligibility assessment. In case of significant change in size exceeding 1cm, the individual participants can continue on the protocol provided all normal tissue contraints are met during planning).\n* Lesion location at least ≥ 2 cm of main, right and left portal vein on the baseline diagnostic MRI. (Subsequent simulation scans will not be used for eligibility assessment. In case of significant change in the distance between the lesion edge and critical structure exceeding 1cm, the individual participants can continue on the protocol provided all normal tissue contraints are met during planning ).\n* Lesion location at least ≥ 1.5 cm of luminal gastrointestinal tract (stomach, small and large bowel). (Subsequent simulation scans will not be used for eligibility assessment. In case of significant change in the distance between the lesion edge and critical structure exceeding 1cm, the individual participants can continue on the protocol provided all normal tissue contraints are met during planning).\n* Lesion location ≥ 0.5 cm of diaphragm\n* Preserved liver function as defined by:\n\n  * Albumin > 2 g/dl\n  * < AST/ ALT ≤ 5 x ULN\n  * Total Bilirubin ≤ 1.5 x UL\n* Negative serum pregnancy test within 14 days prior to simulation and MRgRT for women of childbearing potential\n* Any prior systemic or hepatic artery intraarterial pump (HAIP) chemotherapy is permitted with a washout of 2 weeks\n* Any prior treatment with FDA-approved or investigational biologics or novel molecularly targeted therapies, including oral or IV formulations, are permitted with a washout of 1 weeks or 4 half-lives, which ever is longer\n* Extrahepatic disease outside the liver is permitted\n* Prior liver resection is permitted provided there is enough liver parenchyma to meet normal tissue contraints\n* Prior liver-directed RT is permitted provided departmental normal tissue constraints for re-irradiation can be met\n* Review by HBP DMT prior to enrollment\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Any history of cirrhosis\n* History of hepatic radioembolization or selective internal radiation therapy (SIRT)\n* History of inflammatory bowel disease that precludes liver RT (at the discretion of the treating radiation oncologist).\n* Current pregnancy or breastfeeding\n* Men or women not using effective contraception.\n* Contraindication to or inability to undergo an MR scan, including, but not limited to the history of MR unsafe implants, any implanted cardiac pacemakers or deffibrilators, history of claustrophobia, and contraindications to Gd-EOB-DTPA contrast agent.\n* Concurrent anti-neoplastic therapy of any kind defined as receipt within 1 week of RT administration",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Extrahepatic disease outside the liver is permitted",
            "criterions": [
                {
                    "exact_snippets": "Extrahepatic disease outside the liver is permitted",
                    "criterion": "extrahepatic disease outside the liver",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any prior systemic or hepatic artery intraarterial pump (HAIP) chemotherapy is permitted with a washout of 2 weeks",
            "criterions": [
                {
                    "exact_snippets": "Any prior systemic or hepatic artery intraarterial pump (HAIP) chemotherapy is permitted",
                    "criterion": "prior systemic or hepatic artery intraarterial pump (HAIP) chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "with a washout of 2 weeks",
                    "criterion": "washout period after prior systemic or HAIP chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Lesion location ≥ 0.5 cm of diaphragm",
            "criterions": [
                {
                    "exact_snippets": "Lesion location ≥ 0.5 cm of diaphragm",
                    "criterion": "lesion location",
                    "requirements": [
                        {
                            "requirement_type": "distance from diaphragm",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0.5,
                                "unit": "cm"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Preserved liver function as defined by:",
            "criterions": [
                {
                    "exact_snippets": "Preserved liver function",
                    "criterion": "liver function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "preserved"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Review by HBP DMT prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Review by HBP DMT prior to enrollment",
                    "criterion": "review by HBP DMT",
                    "requirements": [
                        {
                            "requirement_type": "completion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior liver-directed RT is permitted provided departmental normal tissue constraints for re-irradiation can be met",
            "criterions": [
                {
                    "exact_snippets": "Prior liver-directed RT is permitted",
                    "criterion": "prior liver-directed radiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "departmental normal tissue constraints for re-irradiation can be met",
                    "criterion": "normal tissue constraints for re-irradiation",
                    "requirements": [
                        {
                            "requirement_type": "meets departmental constraints",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Albumin > 2 g/dl",
            "criterions": [
                {
                    "exact_snippets": "Albumin > 2 g/dl",
                    "criterion": "albumin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "g/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG 0-2",
            "criterions": [
                {
                    "exact_snippets": "ECOG 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically confirmed colorectal carcinoma and evidence of liver metastasis on imaging",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed colorectal carcinoma",
                    "criterion": "colorectal carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "histology"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of liver metastasis on imaging",
                    "criterion": "liver metastasis",
                    "requirements": [
                        {
                            "requirement_type": "evidence method",
                            "expected_value": "imaging"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total Bilirubin ≤ 1.5 x UL",
            "criterions": [
                {
                    "exact_snippets": "Total Bilirubin ≤ 1.5 x UL",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x UL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any prior treatment with FDA-approved or investigational biologics or novel molecularly targeted therapies, including oral or IV formulations, are permitted with a washout of 1 weeks or 4 half-lives, which ever is longer",
            "criterions": [
                {
                    "exact_snippets": "Any prior treatment with FDA-approved or investigational biologics or novel molecularly targeted therapies, including oral or IV formulations, are permitted with a washout of 1 weeks or 4 half-lives, which ever is longer",
                    "criterion": "prior treatment with biologics or novel molecularly targeted therapies",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment type",
                            "expected_value": [
                                "FDA-approved biologics",
                                "investigational biologics",
                                "novel molecularly targeted therapies"
                            ]
                        },
                        {
                            "requirement_type": "formulation",
                            "expected_value": [
                                "oral",
                                "IV"
                            ]
                        },
                        {
                            "requirement_type": "washout period",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "weeks"
                                    },
                                    {
                                        "operator": ">=",
                                        "value": 4,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Lesion location at least ≥ 1.5 cm of luminal gastrointestinal tract (stomach, small and large bowel). (Subsequent simulation scans will not be used for eligibility assessment. In case of significant change in the distance between the lesion edge and critical structure exceeding 1cm, the individual participants can continue on the protocol provided all normal tissue contraints are met during planning).",
            "criterions": [
                {
                    "exact_snippets": "Lesion location at least ≥ 1.5 cm of luminal gastrointestinal tract (stomach, small and large bowel)",
                    "criterion": "lesion location",
                    "requirements": [
                        {
                            "requirement_type": "distance from luminal gastrointestinal tract",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "cm"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior liver resection is permitted provided there is enough liver parenchyma to meet normal tissue contraints",
            "criterions": [
                {
                    "exact_snippets": "Prior liver resection is permitted",
                    "criterion": "prior liver resection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "provided there is enough liver parenchyma to meet normal tissue contraints",
                    "criterion": "liver parenchyma",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": "enough to meet normal tissue constraints"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Negative serum pregnancy test within 14 days prior to simulation and MRgRT for women of childbearing potential",
            "criterions": [
                {
                    "exact_snippets": "Negative serum pregnancy test within 14 days prior to simulation and MRgRT for women of childbearing potential",
                    "criterion": "serum pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days prior to simulation and MRgRT"
                            }
                        },
                        {
                            "requirement_type": "applicability",
                            "expected_value": "women of childbearing potential"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age ≥18",
            "criterions": [
                {
                    "exact_snippets": "Age ≥18",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Lesion location at least ≥ 2 cm of main, right and left portal vein on the baseline diagnostic MRI. (Subsequent simulation scans will not be used for eligibility assessment. In case of significant change in the distance between the lesion edge and critical structure exceeding 1cm, the individual participants can continue on the protocol provided all normal tissue contraints are met during planning ).",
            "criterions": [
                {
                    "exact_snippets": "Lesion location at least ≥ 2 cm of main, right and left portal vein on the baseline diagnostic MRI.",
                    "criterion": "lesion location relative to portal vein",
                    "requirements": [
                        {
                            "requirement_type": "distance from main, right and left portal vein",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "cm"
                            }
                        },
                        {
                            "requirement_type": "imaging modality",
                            "expected_value": "baseline diagnostic MRI"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* <=3 liver lesions measurable on contrast enhanced diagnostic MRI with combined size (sum of longest diameters) < 7 cm, and individual size < 5cm. (Subsequent simulation scans will not be used for eligibility assessment. In case of significant change in size exceeding 1cm, the individual participants can continue on the protocol provided all normal tissue contraints are met during planning).",
            "criterions": [
                {
                    "exact_snippets": "<=3 liver lesions measurable on contrast enhanced diagnostic MRI",
                    "criterion": "number of liver lesions",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "lesions"
                            }
                        },
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "imaging modality",
                            "expected_value": "contrast enhanced diagnostic MRI"
                        }
                    ]
                },
                {
                    "exact_snippets": "combined size (sum of longest diameters) < 7 cm",
                    "criterion": "combined size of liver lesions",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": "<",
                                "value": 7,
                                "unit": "cm"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "individual size < 5cm",
                    "criterion": "individual liver lesion size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": "<",
                                "value": 5,
                                "unit": "cm"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* < AST/ ALT ≤ 5 x ULN",
            "criterions": [
                {
                    "exact_snippets": "AST/ ALT ≤ 5 x ULN",
                    "criterion": "AST level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "AST/ ALT ≤ 5 x ULN",
                    "criterion": "ALT level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Current pregnancy or breastfeeding",
            "criterions": [
                {
                    "exact_snippets": "Current pregnancy",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "current"
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "current"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Concurrent anti-neoplastic therapy of any kind defined as receipt within 1 week of RT administration",
            "criterions": [
                {
                    "exact_snippets": "Concurrent anti-neoplastic therapy of any kind defined as receipt within 1 week of RT administration",
                    "criterion": "anti-neoplastic therapy",
                    "requirements": [
                        {
                            "requirement_type": "concurrent receipt within 1 week of RT administration",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Men or women not using effective contraception.",
            "criterions": [
                {
                    "exact_snippets": "Men or women not using effective contraception",
                    "criterion": "use of effective contraception",
                    "requirements": [
                        {
                            "requirement_type": "usage",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any history of cirrhosis",
            "criterions": [
                {
                    "exact_snippets": "Any history of cirrhosis",
                    "criterion": "cirrhosis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of hepatic radioembolization or selective internal radiation therapy (SIRT)",
            "criterions": [
                {
                    "exact_snippets": "History of hepatic radioembolization",
                    "criterion": "hepatic radioembolization",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... selective internal radiation therapy (SIRT)",
                    "criterion": "selective internal radiation therapy (SIRT)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of inflammatory bowel disease that precludes liver RT (at the discretion of the treating radiation oncologist).",
            "criterions": [
                {
                    "exact_snippets": "History of inflammatory bowel disease that precludes liver RT (at the discretion of the treating radiation oncologist)",
                    "criterion": "inflammatory bowel disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "precludes liver RT",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Contraindication to or inability to undergo an MR scan, including, but not limited to the history of MR unsafe implants, any implanted cardiac pacemakers or deffibrilators, history of claustrophobia, and contraindications to Gd-EOB-DTPA contrast agent.",
            "criterions": [
                {
                    "exact_snippets": "Contraindication to or inability to undergo an MR scan",
                    "criterion": "ability to undergo MR scan",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of MR unsafe implants",
                    "criterion": "MR unsafe implants",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "any implanted cardiac pacemakers or deffibrilators",
                    "criterion": "implanted cardiac pacemakers or defibrillators",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "history of claustrophobia",
                    "criterion": "claustrophobia",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "contraindications to Gd-EOB-DTPA contrast agent",
                    "criterion": "contraindications to Gd-EOB-DTPA contrast agent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}